HUM vs UNH
Humana and UnitedHealth Group, both Healthcare
UnitedHealth Group is the larger company at $364B against $43B. On trailing earnings UNH is the cheaper of the two at a P/E of 24.4 against 46.0, a gap that is only a bargain if the two are growing at similar rates. Over the past year HUM returned +65% against +16% for UNH. The RyuScore puts UNH ahead, 74 against 73 out of 100.
| Figure | HUM | UNH |
|---|---|---|
| Last close | $431 | $380 |
| Market cap | $43B | $364B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 46.0 | 24.4 |
| Dividend yield | 0.8% | 2.4% |
| 1-year return | +65% | +16% |
| 5-year return | +11% | -0.3% |
| RyuScoresector-relative, 1–10 | 73/100 | 74/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Humana
Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 89% of the disclosed total.
UnitedHealth Group
Revenue of $112B in Q2 2026, net income $5.5B. Its largest reported line is Total Optum, 50% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.